Authors: Shen, GS Layer, RT McCabe, RT

Citation: Gs. Shen et al., Conopeptides: From deadly venoms to novel therapeutics, DRUG DISC T, 5(3), 2000, pp. 98-106

Authors: Donevan, SD McCabe, RT

Citation: Sd. Donevan et Rt. Mccabe, Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors, MOLEC PHARM, 58(3), 2000, pp. 614-623

Authors: Williams, AJ Dave, JR Phillips, JB Lin, Y McCabe, RT Tortella, FC

Citation: Aj. Williams et al., Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: In vitro (Primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies, J PHARM EXP, 294(1), 2000, pp. 378-386

Authors: Lian, HL Steiner, SS Sofia, RD Woodhead, JH Wolf, HH White, HS Shen, GS Rhodes, CA McCabe, RT

Citation: Hl. Lian et al., A self-complementary, self-assembling microsphere system: Application for intravenous delivery of the antiepileptic and neuroprotectant compound felbamate, J PHARM SCI, 89(7), 2000, pp. 867-875

Authors: Adams, AC Layer, RT McCabe, RT Keefe, KA

Citation: Ac. Adams et al., Effects of conantokins on L-3,4-dihydroxyphenylalanine-induced behavior and immediate early gene expression, EUR J PHARM, 404(3), 2000, pp. 303-313

Authors: Rogers, JP Luginbuhl, P Shen, GS McCabe, RT Stevens, RC Wemmer, DE

Citation: Jp. Rogers et al., NMR solution structure of alpha-conotoxin ImI and comparison to other conotoxins specific for neuronal nicotinic acetylcholine receptors, BIOCHEM, 38(13), 1999, pp. 3874-3882